To confirm the differential expression of E2F7 between RG7388-sensitive and -resistant CLL samples, qRT-PCR was performed with a different subset of p53-functional primary CLL samples following treatment with 1 μM RG7388 for 6 h. Here, E2F7 is linked to B-cell chronic lymphocytic leukemia.